CSPC Pharmaceutical Group Limited

BMV:1093 N Stock Report

Market Cap: Mex$151.7b

CSPC Pharmaceutical Group Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Cuilong Zhang

Chief executive officer

CN¥10.7m

Total compensation

CEO salary percentage6.5%
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenure4.4yrs
Board average tenure9.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Cuilong Zhang's remuneration changed compared to CSPC Pharmaceutical Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

CN¥6b

Jun 30 2023n/an/a

CN¥6b

Mar 31 2023n/an/a

CN¥6b

Dec 31 2022CN¥11mCN¥693k

CN¥6b

Sep 30 2022n/an/a

CN¥6b

Jun 30 2022n/an/a

CN¥6b

Mar 31 2022n/an/a

CN¥6b

Dec 31 2021CN¥9mCN¥693k

CN¥6b

Sep 30 2021n/an/a

CN¥6b

Jun 30 2021n/an/a

CN¥6b

Mar 31 2021n/an/a

CN¥5b

Dec 31 2020CN¥9mCN¥693k

CN¥5b

Sep 30 2020n/an/a

CN¥4b

Jun 30 2020n/an/a

CN¥4b

Mar 31 2020n/an/a

CN¥4b

Dec 31 2019CN¥7mCN¥693k

CN¥4b

Sep 30 2019n/an/a

CN¥4b

Jun 30 2019n/an/a

CN¥3b

Mar 31 2019n/an/a

CN¥3b

Dec 31 2018CN¥4mCN¥298k

CN¥3b

Compensation vs Market: Cuilong's total compensation ($USD1.49M) is below average for companies of similar size in the MX market ($USD2.68M).

Compensation vs Earnings: Cuilong's compensation has been consistent with company performance over the past year.

CEO

Cuilong Zhang (54 yo)

1.8yrs

Tenure

CN¥10,684,000

Compensation

Mr. Cuilong Zhang has been the Vice Chairman of CSPC Pharmaceutical Group Ltd since May 21, 2019 and serves as its Chief Executive Officer since May 27, 2022. He was Rotating Chief Executive Officer of CSP...

Leadership Team

NamePositionTenureCompensationOwnership
Dongchen Cai
Executive Chairman26.8yrsCN¥19.66m23.63%
MX$ 35.8b
Cuilong Zhang
Vice-Chairman & CEO1.8yrsCN¥10.68mno data
Chunlei Li
Executive Director & Chief Scientist6.2yrsCN¥7.68mno data
Kin Man Chak
Executive Director18.2yrsCN¥5.28m0.032%
MX$ 49.3m
Weidong Pan
Executive Directorno dataCN¥5.56mno data
Huaiyu Wang
Executive Director13.3yrsCN¥6.39mno data
Zhenguo Wang
Executive Directorno dataCN¥5.53mno data
Qingxi Wang
Executive Director5.5yrsCN¥6.77m0.025%
MX$ 38.4m
Hao Jiang
Executive Director3.3yrsCN¥5.07mno data
Tai On Lo
Company Secretary3.1yrsno datano data

4.4yrs

Average Tenure

55.5yo

Average Age

Experienced Management: 1093 N's management team is considered experienced (4.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dongchen Cai
Executive Chairman26.8yrsCN¥19.66m23.63%
MX$ 35.8b
Cuilong Zhang
Vice-Chairman & CEO5.6yrsCN¥10.68mno data
Chunlei Li
Executive Director & Chief Scientist6.2yrsCN¥7.68mno data
Kin Man Chak
Executive Director18.2yrsCN¥5.28m0.032%
MX$ 49.3m
Weidong Pan
Executive Director17.3yrsCN¥5.56mno data
Huaiyu Wang
Executive Director13.3yrsCN¥6.39mno data
Zhenguo Wang
Executive Director12.1yrsCN¥5.53mno data
Qingxi Wang
Executive Director5.5yrsCN¥6.77m0.025%
MX$ 38.4m
Hao Jiang
Executive Director3.3yrsCN¥5.07mno data
Chun Kwok Au
Independent Non-Executive Director3.1yrsCN¥325.00kno data
Bo Wang
Independent Non-Executive Director11.2yrsCN¥135.00kno data
Chuan Chen
Independent Non-Executive Director7.7yrsCN¥135.00kno data

9.4yrs

Average Tenure

55.5yo

Average Age

Experienced Board: 1093 N's board of directors are considered experienced (9.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/12 02:37
End of Day Share Price 2023/11/15 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CSPC Pharmaceutical Group Limited is covered by 49 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wai Chak YuenBOCI Research Ltd.
Sharon ShiBOCI Research Ltd.
Ethan CuiBofA Global Research